Detalhe da pesquisa
1.
Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10382): 1079-1090, 2023 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36868261
2.
Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 399(10328): 945-955, 2022 03 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35219377
3.
Cat allergen exposure in a naturalistic exposure chamber: A prospective observational study in cat-allergic subjects.
Clin Exp Allergy
; 52(2): 265-275, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34962661
4.
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial.
J Allergy Clin Immunol
; 148(1): 164-172.e9, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33098856
5.
AR101 Oral Immunotherapy for Peanut Allergy.
N Engl J Med
; 379(21): 1991-2001, 2018 Nov 22.
Artigo
Inglês
| MEDLINE | ID: mdl-30449234
6.
Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report.
Allergy
; 76(12): 3589-3612, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34028057
7.
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.
J Allergy Clin Immunol
; 146(4): 863-874, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32659313
8.
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial.
Lancet
; 390(10102): 1595-1602, 2017 Sep 30.
Artigo
Inglês
| MEDLINE | ID: mdl-28754491
9.
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial.
JAMA
; 320(20): 2108-2121, 2018 11 27.
Artigo
Inglês
| MEDLINE | ID: mdl-30480729
10.
FOXP3 Activates SUMO-Conjugating UBC9 Gene in MCF7 Breast Cancer Cells.
Int J Mol Sci
; 19(7)2018 Jul 13.
Artigo
Inglês
| MEDLINE | ID: mdl-30011797
11.
Automated dander dispersal in a cat Naturalistic Exposure Chamber (NEC).
Allergy
; 77(2): 685-687, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34687051
12.
Efficacy and safety of sublingual tablets of house dust mite allergen extracts: Results of a dose-ranging study in an environmental exposure chamber.
J Allergy Clin Immunol
; 138(2): 451-458.e5, 2016 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27289490
13.
Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial.
JAMA
; 318(18): 1798-1809, 2017 11 14.
Artigo
Inglês
| MEDLINE | ID: mdl-29136445
14.
Development and validation of an Allergen Challenge Theater for grass and ragweed.
Allergy
; 74(12): 2531-2533, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31145474
15.
Fel d 1 and Fel d 4 levels in cat fur, saliva, and urine.
J Allergy Clin Immunol
; 142(6): 1990-1992.e3, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30176277
16.
Jun Dimerization Protein 2 (JDP2) Increases p53 Transactivation by Decreasing MDM2.
Cancers (Basel)
; 16(5)2024 Feb 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38473360
17.
Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study.
Lancet Haematol
; 11(6): e436-e447, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38710185
18.
Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy: A Randomized Clinical Trial.
JAMA Pediatr
; 178(4): 345-353, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38407859
19.
Tumor Suppressor p53 Down-Regulates Programmed Cell Death Protein 4 (PDCD4) Expression.
Curr Oncol
; 30(2): 1614-1625, 2023 01 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36826085
20.
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results.
J Allergy Clin Immunol Pract
; 10(7): 1864-1873.e10, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34848381